Cite
HARVARD Citation
Kaufman, H. et al. (n.d.). Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet oncology. 17 (10), pp. 1374-1385. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kaufman, H. et al. (n.d.). Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet oncology. 17 (10), pp. 1374-1385. [Online].